Patent ID: 7317031
Filing Date: 2008-01-08
Classification: A61K,A61P,C07D

Abstract:
1. A method for treating a kinase mediated disorder selected from the group consisting of cervical adenocarcinoma, melanoma, ovarian adenocarcinoma, colon carcinoma, prostate adenocarcinoma, and breast cancer, comprising administering to a subject in need thereof a therapeutically effective amount of a compound of the following formula: wherein R —SO or triazolyl; X is selected from the group consisting of —C(O)—, —C(S)— and —SO R cycloalkyl, thienyl, imidazolinyl, triazolyl, and phenyl, wherein cycloalkyl, thienyl, imidazolinyl, triazolyl, and phenyl are optionally substituted with 1 to 3 substituents independently selected from the group consisting of cyano, halo, hydroxyl, nitro, C and pharmaceutically acceptable salts thereof.